-
InsurTech funding was down 7.3% from $1.09bn in the prior quarter. -
The carrier is consolidating its venture capital activity into asset manager MEAG.
-
The upcoming Lloyd’s Lab cohort 16 will include a dedicated Irish theme.
-
The company will continue its capacity partnership with the MGA until 2030.
-
This will be the 15th cohort of companies to go through the Lloyd’s Lab.
-
The insurer has been under review with positive implications since March.
-
Part III of our series looks at where AI is being integrated into underwriting departments.
-
The lawsuit is the latest development in the multi-billion dollar reinsurance scandal.
-
More investment in early stage firms is an indicator of bullish market, says Gallagher’s Johnston.
-
In part II of our series, we look at where AI is being integrated into claims departments.
-
Plus, the latest people moves and all the top news of the week.
-
The cyber business will continue to operate as a standalone entity.
-
The $2.6bn deal provides Ergo with an entry point to the US SME market.
-
The company said the reduction was due to years of steady improvements.
-
This is up from last year’s $1bn protection for its Florida treaty.
-
The man is alleged to have conspired with others to falsify LOCs and collateral letters.
-
The Corporation is poised to accelerate its investments in start-ups.
-
He will also invest in the company.
-
The Nordic operations have capacity provided by Allianz Commercial.
-
The sale price represents Elephant’s approximate net asset value.
-
The InsurTech was part of the fourth cohort at Lloyd’s lab.
-
Ki cut its top line by 8.7%, while Beazley’s smart-tracker expanded to $481mn.
-
Ahead of the deal, Ergo owned a 29% stake in Next, which generated top line of $548mn last year.
-
Followers will automatically support primary or excess Inigo quotes.
Most Recent
